BMJ Best Practice vs UpToDate: subscription cost, CME and which one to buy

BMJ publishes it, which already sets it apart in this category. On the US edition of bestpractice.bmj.com in September 2026 the subscribe page asks you to pick a profession and then shows two tiers. For a physician, Essential is 250 pounds a year (billed as 20.83 pounds times twelve) and Complete is 324 pounds a year, or 29 pounds a month with the option to cancel. A physician in training pays 144 pounds for Essential and 187 pounds for Complete. Other healthcare professionals, which is where nurse practitioners, physician assistants and pharmacists land, pay 186 pounds and 234 pounds. Students pay 93 pounds and 117 pounds. Tax at the local rate is stated as included.

Two things a US buyer should notice. The prices are shown in pounds sterling even on the US site, so your card issuer converts at the day's rate and may add a foreign transaction fee; check that before you put it on a reimbursement claim. And older references, including the Wikipedia entry, state that only institutional subscriptions were sold in the United States and Canada. That no longer matches what BMJ's own US site presents, which has an individual access route with a free trial, but if your checkout behaves differently by country, that history is why.

Annual subscriptions renew automatically unless you tell BMJ at least 14 days before the renewal date, and they say they send a reminder 28 days ahead. Monthly subscriptions can be stopped by giving notice 14 days before the next renewal. Neither of those is unusual, but they matter if you are buying on a CME allowance that runs on an academic year.

Nobody outside Wolters Kluwer can tell you, and we re-walked the purchase path this month to confirm that. The subscribe page has no figure. The store asks for your country, then whether you are a professional, a student or resident, a group purchaser or a non-clinical user, and the professional route ends at a login screen before any price is shown. The annual figures that circulate on software directories are not vendor-sourced and they disagree with one another, so we do not repeat them. We keep the full account of what is and is not published on our UpToDate subscription cost page.

That asymmetry decides a lot of purchases on its own. If you need a number for a professional development fund before you can get approval, BMJ gives you one today and UpToDate gives you one after you have created an account and asked. If your employer already holds an UpToDate license, which most US hospitals and residency programs do, the price is irrelevant and the question becomes whether BMJ adds enough to be worth buying on top.

UpToDate reads like a chapter. A named author walks you through the epidemiology, the pathophysiology, the evidence and then the recommendation, with a grade attached. If you want to understand why the recommendation is what it is, that is the better read, and it is why UpToDate has the institutional footprint it has in the United States. It is also longer than you need when the patient is in the room and you want one line.

BMJ Best Practice is laid out the way the consultation runs. A topic moves through diagnosis, prognosis, treatment and prevention in that order, with the differentials, the tests to order and the treatment algorithm in short, scannable sections, and every topic carries a list of national and international guidelines grouped by region. It is updated daily. For a clinician who wants to confirm the next step rather than study the condition, it is faster to the answer. The trade is that you get less of the argument behind the recommendation, which is the same trade that separates DynaMed from UpToDate.

The one genuinely different feature is the Comorbidities Manager, which is only on the Complete tier. Open an acute topic such as COPD exacerbation, add the patient's existing conditions, and the initial management plan changes to account for them, using US guidelines on the US edition. BMJ calls it the only point-of-care tool that supports both single conditions and complex comorbidities, and as far as we can find that claim holds. UpToDate handles the same situation inside the narrative of each topic, which works, but it leaves the reconciliation to you.

UpToDate ships with the Lexidrug drug database, the product that used to be called Lexicomp, inside the same subscription, and the drug interactions program that comes with it. For a prescriber that is a real advantage: the monograph, the dosing, the renal adjustment and the interaction check are all one login away from the topic you were reading. We cover what that drug content does and does not include on the UpToDate vs Lexicomp page.

BMJ Best Practice carries drug information inside its treatment sections and lets institutions integrate their own formulary for dosing, formulations, side effects and contraindications, but it is not a standalone drug reference and it is not an interaction checker. A clinician who buys BMJ personally and needs monograph-level drug detail will still need something else for it.

Neither product does the thing that catches most prescribing errors, which is to look at the specific order in front of you and run every check at once. In both, the interaction check, the contraindication check and the renal or hepatic dose adjustment are separate lookups you have to remember to make. Prescriber.io exists for that gap. You enter the drug and the scenario, and the interactions, contraindications, allergy blockers, dose adjustments and guideline-based alternatives arrive together in one card with cited sources, for you to review and sign. It is decision support for a licensed clinician, not a replacement for either reference.

Both earn credit while you work, and the details differ in ways that matter in the US. UpToDate accrues AMA PRA Category 1 credit automatically from searches on a paid personal subscription, with no test, redeemable for up to two years while the subscription is active, and with maintenance of certification submission to several ABMS boards at no added cost. The catch, stated in a footnote on the vendor's own page, is that credit is not available on subscriptions bought at trainee rates. The full mechanics are on our UpToDate CME credits page.

BMJ Best Practice tracks your activity automatically and says it is accredited by over 65 organizations worldwide, naming the Royal College of Physicians, the Royal Australasian College of Physicians and Cleveland Clinic among them. For a US clinician the practical question is whether the credit you claim maps to the body your board or state expects, so check BMJ's accreditation list against your own requirement before relying on it. If credit is the main reason you are buying, and you are a resident, the comparison tilts toward BMJ, because its physician-in-training tier does not strip the CME out the way the UpToDate trainee rate does.

No, and neither is UpToDate. BMJ offers an individual free trial, the mobile app describes a seven day trial, and there are free access codes distributed through some institutions and programs, which is why the query turns up. After the trial it is a paid subscription at the rates above. UpToDate has no standing individual trial on its US store. The one route to either product at no personal cost is an institutional license, so before buying, ask your medical library or residency coordinator which of the two you already have, and whether CME is enabled on it.

If you have neither and are choosing one to pay for, the decision in most US settings comes down to this: UpToDate if you want depth and the Lexidrug drug content in one place and can live with asking for the price, BMJ Best Practice if you want the consultation layout, the comorbidities tool and a published price you can expense today. Whichever you keep, the prescribing checks still have to happen at the moment you sign, and that is the part we built Prescriber.io for.